Search Results - "Robinson, Bridget Anne"

SIRFLOX: Differences in site of first progression between mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 ± bev + selective internal radiation therapy (SIRT) in first-line patients (pts) with metastatic colorectal cancer (mCRC) by Gibbs, Peter, Heinemann, Volker, Sharma, Navesh K., Findlay, Michael P. N., Ricke, Jens, Peeters, Marc, Perez, David, Robinson, Bridget Anne, Strickland, Andrew, Ferguson, Tom, Rodriguez, Javier, Kroening, Hendrik, Wolf, Ido, Ganju, Vinod, Walpole, Euan Thomas, Boucher, Eveline, Tichler, Thomas E., Gebski, Val, Van Buskirk, Mark, Van Hazel, Guy A.

“…Abstract only 637 Background: SIRFLOX, an international multi-centre open-label RCT in first-line pts with non-resectable, liver-only or liver-dominant mCRC,…”
Get full text

Correlation of PI3KCA and extended RAS gene mutation status with outcomes from the phase III AGITG MAX involving capecitabine (C) alone or in combination with bevacizumab (B) with or without mitomycin C (M) in advanced colorectal cancer (CRC) by Price, Timothy Jay, Bruhn, Maressa, Lee, Chee, Hardingham, Jenny, Townsend, Amanda Rose, Mann, Kristy, Simes, John, Weickhardt, Andrew James, Wrin, Joe, Wilson, Kate, Gebski, Val, Robinson, Bridget Anne, Van Hazel, Guy A., Cunningham, David, Tebbutt, Niall C.

“…Abstract only…”
Get full text

Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients by Mackenzie, Katarzyna Anna, Miller, Andrew Peter, Hock, Barry David, Gardner, Jacqui, Simcock, Jeremy William, Roake, Justin Allan, Dachs, Gabi Ursula, Robinson, Bridget Anne, Currie, Margaret Jane

“…Mackenzie K A, Miller A P, Hock B D, Gardner J, Simcock J W, Roake J A, Dachs G U, Robinson B A & Currie M J
(2011) Histopathology 58, 875–885
Angiogenesis and…”
Get full text

Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study by Jackson, Christopher G C A, Sharples, Katrina, Thompson, Paul I, O'Donnell, Anne, Robinson, Bridget Anne, Perez, David J, Adams, Jacqui, Isaacs, Richard, Deva, Sanjeev, Hinder, Victoria A, Findlay, Michael P

“…Dose intense chemotherapy may improve efficacy with acceptable toxicity. A phase II study was conducted to determine the feasibility of a dose-intense two…”
Get full text

Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients: Non-melanoma skin cancers in renal transplant patients by Mackenzie, Katarzyna Anna, Miller, Andrew Peter, Hock, Barry David, Gardner, Jacqui, Simcock, Jeremy William, Roake, Justin Allan, Dachs, Gabi Ursula, Robinson, Bridget Anne, Currie, Margaret Jane

Get full text